电邮这篇文章 Antibiotic treatment failure
- 作者: Alpatov S.1, Bogush N.1, Borozdenko D.1, Buyanova N.1, Ganshina I.1, Dibirova G.1, Dmitrieva N.1, Kalinina E.1, Kirillova A.1, Kiseleva N.1, Kukushkin G.1, Leonteva T.1, Maximov M.1, Markina E.1, Mileshina S.1, Tsitsuashvili M.1, Yurov D.1
-
隶属关系:
- N.I. Pirogov Russian National Research Medical University
- 期: 卷 27, 编号 2 (2021)
- 页面: 175-182
- 栏目: Reviews
- URL: https://journals.rcsi.science/0869-2106/article/view/76378
- DOI: https://doi.org/10.17816/0869-2106-2021-27-2-175-182
- ID: 76378
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
This review presents information on cases of antibiotic failure (insufficient effect) in the global population over the past three years. We analyzed scientific papers, clinical trial data, and the WHO Program for International Drug Monitoring (VigiBase) data from 2018 to 2020. The values of global success and safety rates of antibacterial drugs for medical use are presented. The findings may be of practical interest to physicians, researchers, developers, and healthcare regulators.
作者简介
Sergey Alpatov
N.I. Pirogov Russian National Research Medical University
Email: immunosport@rambler.ru
ORCID iD: 0000-0003-2233-7301
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowNadezhda Bogush
N.I. Pirogov Russian National Research Medical University
Email: nadinbogush@gmail.com
俄罗斯联邦, 1 Ostrovityanova str., 117997, Moscow
Denis Borozdenko
N.I. Pirogov Russian National Research Medical University
Email: borozdenko@phystech.edu
ORCID iD: 0000-0002-6797-9722
俄罗斯联邦, 1 Ostrovityanova str., 117997, Moscow
Natalia Buyanova
N.I. Pirogov Russian National Research Medical University
Email: natasha-buyanova@mail.ru
ORCID iD: 0000-0002-4073-475X
俄罗斯联邦, 1 Ostrovityanova str., 117997, Moscow
Irina Ganshina
N.I. Pirogov Russian National Research Medical University
Email: july1119661@rambler.ru
ORCID iD: 0000-0003-4049-7907
俄罗斯联邦, 1 Ostrovityanova str., 117997, Moscow
Gulnara Dibirova
N.I. Pirogov Russian National Research Medical University
Email: g.dibirova@mail.ru
ORCID iD: 0000-0002-1500-4974
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowNatalia Dmitrieva
N.I. Pirogov Russian National Research Medical University
Email: natapharm@gmail.com
Scopus 作者 ID: 7101760859
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowElena Kalinina
N.I. Pirogov Russian National Research Medical University
Email: lena_vk@mail.ru
Scopus 作者 ID: 8958305800
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowAnna Kirillova
N.I. Pirogov Russian National Research Medical University
Email: kirillova6@yandex.ru
ORCID iD: 0000-0003-3966-4448
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowNina Kiseleva
N.I. Pirogov Russian National Research Medical University
编辑信件的主要联系方式.
Email: kiseleva.67@mail.ru
ORCID iD: 0000-0003-1754-9051
MD, Dr. Sci. (Biol.), Professor
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowGerman Kukushkin
N.I. Pirogov Russian National Research Medical University
Email: germanpharm@yandex.ru
ORCID iD: 0000-0002-1661-1071
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowTatiana Leonteva
N.I. Pirogov Russian National Research Medical University
Email: leontevati@mail.ru
MD, Cand. Sci. (Biol.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowMaxim Maximov
N.I. Pirogov Russian National Research Medical University
Email: maksim_maksimov@mail.ru
ORCID iD: 0000-0002-8979-8084
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowElena Markina
N.I. Pirogov Russian National Research Medical University
Email: elvikmark2015@yandex.ru
ORCID iD: 0000-0002-5943-4423
俄罗斯联邦, 1 Ostrovityanova str., 117997, Moscow
Svetlana Mileshina
N.I. Pirogov Russian National Research Medical University
Email: svetikshrv@rambler.ru
ORCID iD: 0000-0001-8082-9393
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowMaia Tsitsuashvili
N.I. Pirogov Russian National Research Medical University
Email: mayan318@gmail.com
ORCID iD: 0000-0001-7761-8683
MD, Cand. Sci. (Biol.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, MoscowDmitry Yurov
N.I. Pirogov Russian National Research Medical University
Email: dmpharm@gmail.com
ORCID iD: 0000-0003-0178-8736
MD, Cand. Sci. (Med.)
俄罗斯联邦, 1 Ostrovityanova str., 117997, Moscow参考
- Evteev VA, Muslimova OV, Mazerkina IA, et al. Organic anion transporters and their influence on the toxicity of β-lactam antibiotics. Bezopasnost' i risk farmakoterapii. 2017;5(2):70–75. (In Russ).
- Molchan NV, Smirnova YA, Vel'ts NY, et al. Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin. Bezopasnost' i risk farmakoterapii. 2019;7(2):72–83. (In Russ). doi: 10.30895/2312-7821-2019-7-2-72-83
- Ortenberg EA, Khokhlyavina RM, Shpil'kina LV, Khokhlyavin RL. Local antibiotic resistance in a multidisciplinary state: is an annual assessment sufficient? Ural'skii meditsinskii zhurnal. 2007;(6):54–58. (In Russ).
- Ostroumova OD, Kochetkov AI, Pavleeva EE, Kravchenko EV. Drug-Induced Neutropenia and Agranulocytosis. Bezopasnost' i risk farmakoterapii. 2020;8(3):109–122. (In Russ). doi: 10.30895/2312-7821-2020-8-3-109-122
- Ostroumova OD, Shahova EY, Kochetkov AI. Drug-Induced Eosinophilia. Bezopasnost' i risk farmakoterapii. 2019;7(4):176–189. (In Russ). doi: 10.30895/2312-7821-2019-7-4-176-189
- Postnikov SS, Teplova NV, Nikolaev VV, et al. A Case of Multiple Antibiotic-Associated Hepatotoxicity in an Infant. Bezopasnost' i risk farmakoterapii. 2019;7(3):146–151. (In Russ). doi: 10.30895/2312-7821-2019-7-3-146-151
- Reshet'ko OV, Yakimova YN, Novokreshchenova IG. Antibacterials for systemic use as reflected in formularies at different levels. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo. 2016;(3):62–66. (In Russ).
- Titova AR, Pasternak EY, Asetskaya L, et al. On the safety of antibacterial drugs used in pediatrics. Bezopasnost' i risk farmakoterapii. 2015;(2):12–22. (In Russ).
- Yakovlev S. Modern problems of antibiotic resistance in the hospital. Vrach. 2007;(1):9–12. (In Russ).
- elibrary [Internet]. Nauchnaya elektronnaya biblioteka [cited 25 Feb 2021]. Available from: https://elibrary.ru
- ncbi.nlm.nih.gov [Internet]. PubMed [cited 25 Feb 2021]. Available from: https://pubmed.ncbi.nlm.nih.gov
- Clinicaltrials [Internet]. Clinicaltrials [cited 25 feb 2021]. Available from: https://clinicaltrials.gov
- vigilyze [Internet]. Vigilyze [cited 25 Feb 2021]. Available from: https://vigilyze.who-umc.org
- Solodukhina OA, Verlan NV, Kochkina EO, Rozhkova NY. Monitoring of antibacterial drug safety in clinical practice. Izvestiya vuzov. Prikladnaya khimiya i biotekhnologiya. 2018;8(2):117–124. (In Russ). doi: 0.21285/2227-2925-2018-8-2-117-124
补充文件
